EKSO BIONICS HOLDINGS, INC. (EKSO) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 160 transactions totaling $1.6M, demonstrating a bearish sentiment with -$801.5K in net insider flow. The most recent transaction on Jan 6, 2026 involved a sale of 1,320 shares valued at $12.2K.
No significant insider buying has been recorded for EKSO in the recent period.
No significant insider selling has been recorded for EKSO in the recent period.
Based on recent SEC filings, insider sentiment for EKSO is bearish with an Insider Alignment Score of 25/100 and a net flow of -$801.5K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at EKSO BIONICS HOLDINGS, INC. (EKSO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading EKSO stock, having executed 160 transactions in the past 90 days. The most active insider is Russ Angold (Executive), who has made 9 transactions totaling $780.7K.
Get notified when executives and directors at EKSO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | C. Jones Jason | Chief Operating Officer | Sale | 1,320 | $9.25 | $12.2K | C-Suite |
| Dec 9, 2025 | Wong Jerome | Executive | Sale | 1,238 | $4.70 | $5.8K | |
| Dec 9, 2025 | C. Jones Jason | Executive | Sale | 270 | $4.70 | $1.3K | |
| Nov 10, 2025 | G. Davis Scott | Executive | Sale | 23,315 | $4.80 | $111.9K | |
| Nov 10, 2025 | C. Jones Jason | Executive | Sale | 9,723 | $4.80 | $46.7K | |
| Nov 10, 2025 | Wong Jerome | Executive | Sale | 11,288 | $4.80 | $54.2K | |
| Nov 5, 2025 | Wong Jerome | Executive | Award | 19,500 | $N/A | $0 | |
| Nov 5, 2025 | C. Jones Jason | Executive | Award | 15,000 | $N/A | $0 | |
| Nov 5, 2025 | G. Davis Scott | Executive | Award | 80,000 | $N/A | $0 | |
| Jun 6, 2024 | Lafer Scher Deborah | Executive | Award | 78,217 | $N/A | $0 | |
| Jun 6, 2024 | Li Kecheng | Executive | Award | 78,217 | $N/A | $0 | |
| Jun 6, 2024 | Lathan Corinna | Executive | Award | 78,217 | $N/A | $0 | |
| Jun 6, 2024 | Ann Cloyd Mary | Executive | Award | 78,217 | $N/A | $0 | |
| Mar 22, 2024 | C. Jones Jason | Executive | Award | 7,474 | $N/A | $0 | |
| Mar 22, 2024 | Wong Jerome | Executive | Award | 7,474 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 40 | $1.2M | 59.4% |
Purchase(P) | 11 | $399.1K | 19.7% |
Exercise (Options)(X) | 6 | $239.9K | 11.9% |
Award(A) | 81 | $113.4K | 5.6% |
Payment(F) | 6 | $69.2K | 3.4% |
Exercise(M) | 14 | $0 | 0.0% |
Other(J) | 2 | $0 | 0.0% |
Insider selling pressure at EKSO BIONICS HOLDINGS, INC. has increased, with 25 insiders executing 160 transactions across all time. Total sales of $1.2M significantly outpace purchases of $399.1K, resulting in a net outflow of $801.5K. This selling activity appears largely discretionary, which may warrant closer attention from investors.